Navigation Links
HerKare Launched To Exclusively Treat Hormone Imbalance In Women
Date:11/11/2013

SOUTHLAKE, Texas, Nov. 11, 2013 /PRNewswire/ -- HerKare opened its doors today to help relieve women suffering from hormone imbalance.  The physicians and treatment professionals at HerKare will focus on improving the overall health and well-being of women through bioidentical hormone replacement therapy (BHRT).  BHRT is not synthetic, rather it is personalized to each patient's specific needs and body chemistry.

Whether a patient is suffering from the effects of post pregnancy, a genetic deficiency, or stages of menopause, the physicians at HerKare will develop a customized treatment plan designed to support and improve common symptoms of hormone imbalance, including fatigue, depression, low libido, weight gain, hot flashes and/or muscle loss.

Mickala Sisk, founder of the HerKare concept explains, "Hormone imbalance is an inevitable part of every woman's life, and women have traditionally not been satisfied with the options available.  As a working mom, I can relate and empathize.  I wanted to create a place where women of all ages could get real help and bring balance back into their life."

Hormone imbalance can be the cause of a variety of health issues and some studies link hormone imbalance to the risk of more serious ailments such as heart disease, osteoporosis, stroke, memory loss, high cholesterol, depression and mood swings.  Fortunately imbalances are treatable.  Dr. Bradley Axline M.D., OB/GYN explains, "With the right treatment modalities, patients should begin to experience the benefits of treatment within the first few visits.  Of course, careful monitoring is important to maintain consistent results over the treatment cycle."

To determine if an imbalance exists, the doctors at HerKare evaluate patients in seven areas of potential deficiencies:  Estrogen, Progesterone, Testosterone, thyroid function, Folate, Vitamin D and B12.  Treatment options could include modalities such as injections, prescriptions and/or supplements.

Most insurance is accepted, and with the convenience of an on-site lab, immediate treatment is available during the initial visit.

HerKare is located at 560 North Kimball, Suite 100, Southlake, TX 76092. Hours of operation are Monday through Friday, 8:30 a.m. to 5:30 p.m. Appointments can be scheduled by calling (817) 488-6205 or via email Info@HerKare.com.

About HerKare

HerKare was founded in 2013 to create a female-friendly environment where understanding professionals exclusively treat hormone imbalance in women. Specifically focusing on estrogen, progesterone, testosterone, thyroid, folate, Vitamin D and B12 deficiencies, HerKare's mission is to improve the overall health and well-being of women through bioidentical hormone replacement therapy.  Visit www.HerKare.com for more information.


'/>"/>
SOURCE HerKare
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. FreeMyGenes.org and Facebook Campaign Launched to Raise Awareness of Fight to Make Genetic Testing for Breast and Other Cancers More Affordable and Accessible
2. China Green Agriculture, Inc. Launched Five New Fertilizer Products and Added 39 New Distributors during the Fourth Quarter of Fiscal Year 2013
3. Hard-Cover Catalog on Precision Motion Control Technology Launched by PI
4. PlantCellCulture.com Launched by DianaPlantSciences to Educate Industry and Consumers About Benefits of Plant Cell Culture Technology
5. Anonymous survey launched for Parkinson’s patients to collect data for research to help determine the cause of Parkinson's disease.
6. New Haydale HDPlas™ inks launched at Printed Electronics 2012
7. New Egg Donation Program, "Ovatures," Launched By Reproductive Medicine Associates Of New Jersey
8. Probiotic-Enriched Instant Chai Latte and Teas to be Launched by Ganeden Biotech and Tipton Mills
9. New HydraSolve™ Lipoplasty System launched at American Society of Aesthetic Plastic Surgery Meeting
10. Foundation for Health Improvement and Technology (FHIT) Launched to Beat Cardiovascular Disease
11. Healthcare IT Accelerator Launched
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the ... today the Clinical Reach Virtual Patient Encounter CONSULT module which enables both ... physician and clinical trial team. , Using the CONSULT module, patients and physicians can ...
(Date:6/27/2016)... Chapel Hill, N.C. (PRWEB) , ... June 27, ... ... of U.S. commercial operations for Amgen, will join the faculty of the ... will serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology:
(Date:6/21/2016)... June 21, 2016 NuData Security announced today ... role of principal product architect and that ... of customer development. Both will report directly to ... The moves reflect NuData,s strategic growth in its ... high customer demand and customer focus values. ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems is ... log work hours, for employers to make sure the right employees are actually signing ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
Breaking Biology News(10 mins):